Ahmedabad, India

Arun Singh

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Cadila Healthcare Limited, Zydus Lifesciences Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arun Singh. Retrieved from https://idiyas.com/inventor/arun-singh-n3bo72mu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.9

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Arun Singh: Innovator in Antibody Research

Introduction

Arun Singh is a prominent inventor based in Ahmedabad, India. He has made significant contributions to the field of antibody research, holding a total of 2 patents. His work focuses on developing innovative solutions that have the potential to impact medical science.

Latest Patents

Among his latest patents are "Anti-Properdin Antibodies and Preparation Thereof" and "Antibodies to Human Programmed Death Receptor PD-1." These patents reflect his dedication to advancing therapeutic options in immunology.

Career Highlights

Arun Singh has worked with notable companies such as Cadila Healthcare Limited and Zydus Lifesciences Limited. His experience in these organizations has allowed him to hone his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

He has collaborated with talented individuals like Aashini Parikh and Pankaj Kalita, further enhancing the innovative environment in which he works.

Conclusion

Arun Singh's contributions to antibody research and his impressive patent portfolio underscore his role as a key innovator in the field. His work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…